Submitted by Anonymous (not verified) on 27 August 2025 - 16:00
Human medicines European public assessment report (EPAR): Kyntheum, brodalumab, Date of authorisation: 17/07/2017, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kyntheum, brodalumab, Date of authorisation: 17/07/2017, Revision: 7, Status: Authorised